Exclusive-Activist investor Ananym Capital pushes for changes at Henry Schein, sources say
Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut ...
Seeking Alpha on MSN8h
Henry Schein extends gain on report of activist stake, push for board changes
Henry Schein (NASDAQ:HSIC) rose 7.4% amid a report that an activist investor has taken a stake and is pushing for the dental ...
Henry Schein gains amid activist speculation after 13F filing, conference appearance
Henry Schein (NASDAQ:HSIC) advanced 5.3% following a 3.3% increase on Friday amid some speculation the dental products ...
MarketWatch5h
Henry Schein Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Business Insider14h
Ananym urges Henry Schein to cut spending, sell unit, Reuters reports
Activist Ananym Capital Management is urging Henry Schein (HSIC) to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, Svea Herbst-Bayliss ...
Dental supply stock rallies on theory RFK's anti-fluoride stance will prompt more dentist visits
Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect ...
NBC Los Angeles9h
Dental supply stock surges on RFK's anti-fluoride stance, activist involvement
Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect ...
Yahoo Finance5d
Some Investors May Be Willing To Look Past Henry Schein's (NASDAQ:HSIC) Soft Earnings
The most recent earnings report from Henry Schein, Inc. (NASDAQ:HSIC) was disappointing for shareholders. However, our analysis suggests that the soft headline numbers are getting counterbalanced by ...
Henry Schein: Buy Rating Affirmed Amid Strong Profitability and Strategic Cost Management
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...
Analyst Ratings For Henry Schein
The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...
Henry Schein Q3 Earnings: Sees Recovery From Cyber Incident, Says Dental Equipment Business Shows Stability In North America
Henry Schein posts Q3 adjusted EPS of $1.23, topping forecasts, while sales of $3.17 billion fall short. The company revises ...